nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker
|
Duvall, Bridget |
|
|
28 |
20 |
p. |
artikel |
2 |
A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer's disease
|
Rivera-Marrero, Suchitil |
|
|
28 |
20 |
p. |
artikel |
3 |
An orthogonal seryl-tRNA synthetase/tRNA pair for noncanonical amino acid mutagenesis in Escherichia coli
|
Zambaldo, Claudio |
|
|
28 |
20 |
p. |
artikel |
4 |
Design, synthesis and evaluation of a baicalin and berberine hybrid compound as therapeutic agent for ulcerative colitis
|
Jia, Dan |
|
|
28 |
20 |
p. |
artikel |
5 |
Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity
|
Chen, Huan |
|
|
28 |
20 |
p. |
artikel |
6 |
Editorial Board
|
|
|
|
28 |
20 |
p. |
artikel |
7 |
Exploring the physicochemical and antiproliferative properties of biaryl-linked [13]-macrodilactones
|
Chen, Chengsheng |
|
|
28 |
20 |
p. |
artikel |
8 |
Fragment-based modification of 2,4-diarylaminopyrimidine derivatives as ALK and ROS1 dual inhibitors to overcome secondary mutants
|
Zhu, Minglin |
|
|
28 |
20 |
p. |
artikel |
9 |
Graphical Abstract Contents Continued
|
|
|
|
28 |
20 |
p. |
artikel |
10 |
Graphical abstract TOC
|
|
|
|
28 |
20 |
p. |
artikel |
11 |
Graphical abstract TOC
|
|
|
|
28 |
20 |
p. |
artikel |
12 |
Protection of all cleavable sites of DNA with the multiple CGCG or continuous CGG sites from the restriction enzyme, indicative of simultaneous binding of small ligands
|
Murase, Hirotaka |
|
|
28 |
20 |
p. |
artikel |
13 |
Pyrroformyl-containing 2,4-diaminopyrimidine derivatives as a new optimization strategy of ALK inhibitors combating mutations
|
Cao, Meng |
|
|
28 |
20 |
p. |
artikel |
14 |
Rational design of cell-permeable cyclic peptides containing a d-Pro-l-Pro motif
|
Wen, Jin |
|
|
28 |
20 |
p. |
artikel |
15 |
Recent advances in the design of RAR α and RAR β agonists as orally bioavailable drugs. A review
|
Borthwick, Alan D. |
|
|
28 |
20 |
p. |
artikel |
16 |
RNA drug discovery: Conformational restriction enhances specific modulation of the T-box riboswitch function
|
Armstrong, Ian |
|
|
28 |
20 |
p. |
artikel |
17 |
Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-β-hydroxylase
|
Brewitz, Lennart |
|
|
28 |
20 |
p. |
artikel |
18 |
Synthesis, biological evaluation and in silico modeling of novel pan-genotypic NS5A inhibitors
|
Ivashchenko, Andrey A. |
|
|
28 |
20 |
p. |
artikel |
19 |
The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells
|
Melnyk, James E. |
|
|
28 |
20 |
p. |
artikel |
20 |
Widening the bottleneck: Heterologous expression, purification, and characterization of the Ktedonobacter racemifer minimal type II polyketide synthase in Escherichia coli
|
Klein, Joshua G. |
|
|
28 |
20 |
p. |
artikel |